Quarterly report [Sections 13 or 15(d)]

DERIVATIVES (Tables)

v3.26.1
DERIVATIVES (Tables)
3 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Summary of the Derivatives

The following table summarizes key elements of the Company’s derivative instruments as of the periods ended, segregated by derivatives that are considered accounting hedges and those that are not (dollars in thousands):

March 31, 2026

  ​ ​ ​

December 31, 2025

Derivative (2)

Derivative (2)

Notional or

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Notional or

  ​ ​ ​

  ​ ​ ​

Contractual

Contractual

Amount (1)

Assets

Liabilities

Amount (1)

Assets

Liabilities

Derivatives designated as accounting hedges:

Interest rate contracts: (3)

 

  ​

 

  ​

 

  ​

 

  ​

Cash flow hedges

$

900,000

$

583

$

1,829

$

900,000

$

1,444

$

643

Fair value hedges:

 

 

 

 

 

 

Loans

62,717

652

63,993

635

Securities

50,000

301

50,000

294

Derivatives not designated as accounting hedges:

Interest rate contracts (3)(4)

 

11,020,241

 

99,357

 

155,140

 

10,530,098

 

110,311

 

165,860

Foreign exchange contracts

9,153

39

161

6,266

2

187

Cash collateral (received)/pledged (5)

$

$

(21,225)

$

4,250

$

$

(21,297)

$

3,970

(1) Notional amounts are not recorded on the Company’s Consolidated Balance Sheets and are generally used only as a basis on which interest and other payments are determined.

(2) Balances represent fair value of derivative financial instruments.

(3) The Company’s cleared derivatives are classified as a single-unit of accounting, resulting in the fair value of the designated swap being reduced by the variation margin, which is treated as settlement of the related derivatives fair value for accounting purposes and is reported on a net basis.

(4) Includes Risk Participation Agreements.

(5) The fair value of derivative assets and liabilities is presented on a gross basis. The Company has not applied collateral netting; as such the amounts of cash collateral received or pledged are not offset against the derivative assets and derivative liabilities in the Consolidated Balance Sheets. Cash collateral received is included in “Interest-bearing deposits in other banks” and cash collateral pledged is included in “Other liabilities” on the Company’s Consolidated Balance Sheets.

Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location

The following table summarizes the carrying value of the Company’s hedged assets in fair value hedges and the associated cumulative basis adjustments included in those carrying values as of the periods ended (dollars in thousands):

March 31, 2026

December 31, 2025

  ​ ​ ​

  ​ ​ ​

Cumulative

  ​ ​ ​

  ​ ​ ​

Cumulative

Amount of Basis

Amount of Basis

Adjustments

Adjustments

Included in the

Included in the

Carrying Amount

Carrying

Carrying Amount

Carrying

of Hedged

Amount of the

of Hedged

Amount of the

Assets/(Liabilities)

Hedged

Assets/(Liabilities)

Hedged

Amount (1)

 

Assets/(Liabilities)

Amount (1)

 

Assets/(Liabilities)

Line items on the Consolidated Balance Sheets in which the hedged item is included:

 

  ​

 

  ​

 

  ​

 

  ​

Securities available-for-sale (1) (2)

$

64,928

$

(294)

$

66,763

$

(292)

Loans (3)

 

62,717

 

(7,874)

 

63,993

 

(7,908)

(1) These amounts include the amortized cost basis of the investment securities designated in hedging relationships for which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. The amount of the designated hedged item at March 31, 2026 and December 31, 2025 totaled $50 million.

(2) Carrying value represents amortized cost.

(3) The fair value of the swaps associated with the derivative related to hedged items was $8.0 million at March 31, 2026 and December 31, 2025.